AM
Angelos M. Stergiou sold $510K of SLS stock
Angelos M. Stergiou, President and CEO of SELLAS Life Sciences Group, Inc. (SLS), sold 26,606 shares of SLS stock worth $510K, per an SEC Form 4 filed Nov 21, 2026.
It was an open-market sale.
The trade happened on Nov 18, 2026, 3 days before it was made public.
SLS has moved +0.0% since the trade date, from $17.95 to $17.95 (Nov 18, 2026 close).
- Traded
- Nov 18, 2026
- Disclosed
- Nov 21, 2026
- Filing delay
- 3 days
- Price since
- +0.0%
- Role
- President and CEO
- Source
- SEC Form 4